Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Yan, XY; Clemens, PL; Puchalski, T; Lonial, S; Lokhorst, H; Voorhees, PM; Usmani, S; Richardson, PG; Plesner, T; Liu, K; Orlowski, RZ; Losic, N; Jansson, R; Ahmadi, T; Lantz, K; Ruixo, JJP; Zhou, HH; Xu, XS

Xu, XS (reprint author), Janssen Res & Dev LLC, Raritan, NJ 08869 USA.

CLINICAL PHARMACOKINETICS, 2018; 57 (4): 529

Abstract

Objective The aim of this study was to understand the influence of disease and patient characteristics on exposure to daratumumab, an immunoglobulin G......

Full Text Link